Hycodan and Fosamax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hycodan (homatropine methylbromide; hydrocodone bitartrate) and Fosamax (alendronate sodium). Common drug interactions include ascites among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Hycodan and Fosamax. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Hycodan?

Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 769 Hycodan users. Check the latest studies of Hycodan.

What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.



On Jul, 12, 2026

19 people who take Hycodan and Fosamax together, and have interactions are studied.

Hycodan and Fosamax drug interactions.

What are the common drug interactions of Hycodan and Fosamax, by gender? *:

female:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Abdominal pain
  3. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  4. Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
  5. Cardiomegaly (increased size of heart than normal)
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Generalised oedema (swelling all over the body)
  9. Headache (pain in head)
  10. Hepatic haemorrhage (bleeding inside liver)

male:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Hycodan and Fosamax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaemia (lack of blood)
  2. Abdominal pain
  3. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  4. Asthenia (weakness)
  5. Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
  6. Cardiomegaly (increased size of heart than normal)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Dehydration (dryness resulting from the removal of water)
  9. Diarrhoea
  10. Disease progression

60+:

  1. Dyspepsia (indigestion)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Idiopathic pulmonary fibrosis (chronic lung disease)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Uterine cancer

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 8 people, 42.11%
  2. High Blood Pressure: 6 people, 31.58%
  3. Pain: 4 people, 21.05%
  4. Nausea (feeling of having an urge to vomit): 4 people, 21.05%
  5. Ascites (accumulation of fluid in the abdominal cavity): 3 people, 15.79%
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 15.79%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 15.79%
  8. Pain In Extremity: 3 people, 15.79%
  9. Oedema (fluid collection in tissue): 2 people, 10.53%
  10. Diarrhea: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Hycodan and Fosamax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hycodan and Fosamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hycodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fosamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hycodan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fosamax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on homatropine methylbromide; hydrocodone bitartrate and alendronate sodium (the active ingredients of Hycodan and Fosamax, respectively), and Hycodan and Fosamax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: